Journal article · 2002
Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study
European Neuropsychopharmacology, 12, 309–310 · Published 1 October 2002 · DOI 10.1016/s0924-977x(02)80457-6
In brief
“Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study” is a 2002 journal article by Werner Rein and Odile Fleurot, published in European Neuropsychopharmacology. OpenAlex counts 3 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 3
- Most cited in
- 2016 (1)
- Field-weighted impact
- 0.18
- Authors
- 2
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rein, W., & Fleurot, O. (2002). Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study. European Neuropsychopharmacology, 12, 309–310. https://doi.org/10.1016/s0924-977x(02)80457-6
MLA 9
Rein, Werner, and Odile Fleurot. “Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study.” European Neuropsychopharmacology, vol. 12, 2002, pp. 309–310. https://doi.org/10.1016/s0924-977x(02)80457-6.
Chicago
Rein, Werner and Odile Fleurot. 2002. “Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study.” European Neuropsychopharmacology 12: 309–310. https://doi.org/10.1016/s0924-977x(02)80457-6.
Harvard
Rein, W. and Fleurot, O. (2002) ‘Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study’, European Neuropsychopharmacology, 12, pp. 309–310. doi:10.1016/s0924-977x(02)80457-6.
IEEE
W. Rein and O. Fleurot, “Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study,” European Neuropsychopharmacology, vol. 12, pp. 309–310, 2002, doi: 10.1016/s0924-977x(02)80457-6.
BibTeX
@article{rein2002safety,
title = {{Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study}},
author = {Rein, Werner and Fleurot, Odile},
journal = {European Neuropsychopharmacology},
year = {2002},
volume = {12},
pages = {309--310},
doi = {10.1016/s0924-977x(02)80457-6},
url = {https://doi.org/10.1016/s0924-977x(02)80457-6}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- amisulpride
- risperidone
- chronic schizophrenia
- long-term antipsychotic treatment
- negative symptoms
- atypical antipsychotics
- extrapyramidal symptoms
- drug safety
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Rein, W., & Fleurot, O. (2002). Safety of amisulpride vs risperidone in the long-term treatment of chronic schizophrenia: Results from a 12 month double-blind study. European Neuropsychopharmacology, 12, 309–310. https://doi.org/10.1016/s0924-977x(02)80457-6
How many times has this paper been cited?
3 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Werner Rein, Odile Fleurot.
What is the DOI of this paper?
10.1016/s0924-977x(02)80457-6, permanently at https://doi.org/10.1016/s0924-977x(02)80457-6. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.